MoneyWorks4Me

Lasa Supergenerics - Quaterly Results

08 Aug 2022 Evaluate
The sales is pegged at Rs. 288.79 millions for the June 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 360.66 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -120.84 millions as compared to Net Profit of Rs. 8.06 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -81.19% as compared to 46.42% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 288.79 360.66 -19.93 288.79 360.66 -19.93 1371.27 2023.80 -32.24
Other Income 0.09 0.15 -40.00 0.09 0.15 -40.00 0.57 0.58 -1.72
PBIDT -81.19 46.42 -274.90 -81.19 46.42 -274.90 156.89 472.79 -66.82
Interest 0.09 0.28 -67.86 0.09 0.28 -67.86 0.40 19.63 -97.96
PBDT -81.28 46.14 -276.16 -81.28 46.14 -276.16 77.89 453.16 -82.81
Depreciation 30.66 34.71 -11.67 30.66 34.71 -11.67 139.99 158.24 -11.53
PBT -111.94 11.43 -1079.35 -111.94 11.43 -1079.35 -62.10 294.92 -121.06
TAX 8.90 3.37 164.09 8.90 3.37 164.09 -8.42 67.14 -112.54
Deferred Tax 8.90 -0.84 -1159.52 8.90 -0.84 -1159.52 -14.62 56.47 -125.89
PAT -120.84 8.06 -1599.26 -120.84 8.06 -1599.26 -53.68 227.78 -123.57
Equity 406.73 406.73 0.00 406.73 406.73 0.00 406.73 406.73 0.00
PBIDTM(%) -28.11 12.87 -318.43 -28.11 12.87 -318.43 11.44 23.36 -51.03
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..